These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24939246)

  • 41. Involvement of chromosome 22 in ependymomas.
    Wernicke C; Thiel G; Lozanova T; Vogel S; Kintzel D; Jänisch W; Lehmann K; Witkowski R
    Cancer Genet Cytogenet; 1995 Feb; 79(2):173-6. PubMed ID: 7889515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MYCN amplification drives an aggressive form of spinal ependymoma.
    Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
    Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular analysis of genetic changes in ependymomas.
    Bijlsma EK; Voesten AM; Bijleveld EH; Troost D; Westerveld A; Mérel P; Thomas G; Hulsebos TJ
    Genes Chromosomes Cancer; 1995 Aug; 13(4):272-7. PubMed ID: 7547635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases.
    Rajaram V; Leuthardt EC; Singh PK; Ojemann JG; Brat DJ; Prayson RA; Perry A
    Mod Pathol; 2004 Jan; 17(1):9-14. PubMed ID: 14631364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytogenetic findings in a supratentorial ependymoma.
    Dal Cin P; Sandberg AA
    Cancer Genet Cytogenet; 1988 Feb; 30(2):289-93. PubMed ID: 3342386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma.
    Rousseau E; Palm T; Scaravilli F; Ruchoux MM; Figarella-Branger D; Salmon I; Ellison D; Lacroix C; Chapon F; Mikol J; Vikkula M; Godfraind C
    Mol Cancer; 2007 Jul; 6():47. PubMed ID: 17626628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas.
    Ransom DT; Ritland SR; Kimmel DW; Moertel CA; Dahl RJ; Scheithauer BW; Kelly PJ; Jenkins RB
    Genes Chromosomes Cancer; 1992 Nov; 5(4):348-56. PubMed ID: 1283324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).
    Kilday JP; Mitra B; Domerg C; Ward J; Andreiuolo F; Osteso-Ibanez T; Mauguen A; Varlet P; Le Deley MC; Lowe J; Ellison DW; Gilbertson RJ; Coyle B; Grill J; Grundy RG
    Clin Cancer Res; 2012 Apr; 18(7):2001-11. PubMed ID: 22338015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytogenetic abnormalities in human ependymomas.
    Stratton MR; Darling J; Lantos PL; Cooper CS; Reeves BR
    Int J Cancer; 1989 Oct; 44(4):579-81. PubMed ID: 2793229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas.
    Rousseau-Merck M; Versteege I; Zattara-Cannoni H; Figarella D; Lena G; Aurias A; Vagner-Capodano AM
    Cancer Genet Cytogenet; 2000 Sep; 121(2):223-7. PubMed ID: 11063814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytogenetic analysis of 109 pediatric central nervous system tumors.
    Neumann E; Kalousek DK; Norman MG; Steinbok P; Cochrane DD; Goddard K
    Cancer Genet Cytogenet; 1993 Nov; 71(1):40-9. PubMed ID: 8275451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Karyotypes in 90 human gliomas.
    Thiel G; Losanowa T; Kintzel D; Nisch G; Martin H; Vorpahl K; Witkowski R
    Cancer Genet Cytogenet; 1992 Feb; 58(2):109-20. PubMed ID: 1551072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural genomic abnormalities of chromosomes 9 and 18 in myxopapillary ependymomas.
    Mahler-Araujo MB; Sanoudou D; Tingby O; Liu L; Coleman N; Ichimura K; Collins VP
    J Neuropathol Exp Neurol; 2003 Sep; 62(9):927-35. PubMed ID: 14533782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytogenetics of pediatric central nervous system tumors.
    Sainati L; Bolcato S; Montaldi A; Celli P; Stella M; Leszl A; Silvestro L; Perilongo G; Cordero di Montezemolo L; Basso G
    Cancer Genet Cytogenet; 1996 Oct; 91(1):13-27. PubMed ID: 8908162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas.
    Shatara M; Schieffer KM; Klawinski D; Thomas DL; Pierson CR; Sribnick EA; Jones J; Rodriguez DP; Deeg C; Hamelberg E; LaHaye S; Miller KE; Fitch J; Kelly B; Leraas K; Pfau R; White P; Magrini V; Wilson RK; Mardis ER; Abdelbaki MS; Finlay JL; Boué DR; Cottrell CE; Ghasemi DR; Pajtler KW; Osorio DS
    Acta Neuropathol Commun; 2021 Dec; 9(1):192. PubMed ID: 34895332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
    Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
    Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of chromosome 22 and proliferative potential in ependymomas.
    Debiec-Rychter M; Biernat W; Zakrzewski K; Krul W; Liberski PP
    Folia Neuropathol; 2003; 41(4):191-5. PubMed ID: 14977248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of heterozygosity on chromosome 22 in human ependymomas.
    Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
    Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic relevance of localization and grading in intracranial ependymomas of childhood.
    Ernestus RI; Schröder R; Stützer H; Klug N
    Childs Nerv Syst; 1996 Sep; 12(9):522-6. PubMed ID: 8906366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.